178 related articles for article (PubMed ID: 18274844)
1. Guidelines for chemotherapy of biliary tract and ampullary carcinomas.
Furuse J; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Saito H; Tsuyuguchi T; Hirata K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):55-62. PubMed ID: 18274844
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas.
Saito H; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Tsuyuguchi T; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):63-8. PubMed ID: 18274845
[TBL] [Abstract][Full Text] [Related]
3. Role of chemotherapy in treatments for biliary tract cancer.
Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant treatments for biliary tract cancer.
Furuse J
J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
Konishi M
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.
Kondo S; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Furuse J; Saito H; Tsuyuguchi T; Yamamoto M; Kayahara M; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Hirano S; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):41-54. PubMed ID: 18274843
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Hachem GE; Ceppi M; Lambertini M; Glasberg J; de Azambuja E; Van Laethem JL; Hendlisz A
Crit Rev Oncol Hematol; 2020 May; 149():102940. PubMed ID: 32252001
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
[TBL] [Abstract][Full Text] [Related]
10. [Current status of adjuvant therapy for biliary tract cancer].
Kato A; Miyazaki M
Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature.
Hejna M; Pruckmayer M; Raderer M
Eur J Cancer; 1998 Jun; 34(7):977-86. PubMed ID: 9849443
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in biliary tract cancer.
Tonini G; Frato ME; Vincenzi B; Santini D
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):371-4. PubMed ID: 20496551
[TBL] [Abstract][Full Text] [Related]
13. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment in biliary tract cancer: to treat or not to treat?
Cereda S; Belli C; Reni M
World J Gastroenterol; 2012 Jun; 18(21):2591-6. PubMed ID: 22690066
[TBL] [Abstract][Full Text] [Related]
15. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
[TBL] [Abstract][Full Text] [Related]
16. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
17. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of Prognostic Factors in Patients with Relapse and Unresectable Biliary Tract Cancer, Treated with S-1 after Failure of Gemcitabine].
Nakai M; Kikkawa A; Funahara H; Matsumoto S; Hiraki K
Yakugaku Zasshi; 2022; 142(9):1021-1029. PubMed ID: 36047214
[TBL] [Abstract][Full Text] [Related]
19. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas.
Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Saito H; Tsuyuguchi T; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):2-6. PubMed ID: 18274838
[TBL] [Abstract][Full Text] [Related]
20. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
